- Home
- POM vs NMTC Comparison
POM vs NMTC Comparison
Compare POM & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | POM | NMTC |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.2M | 39.5M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | POM | NMTC |
|---|---|---|
| Price | $0.31 | $0.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $1.98 |
| AVG Volume (30 Days) | ★ 629.7K | 132.8K |
| Earning Date | 05-03-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,097,692.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $31.90 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 163.47 |
| 52 Week Low | $0.19 | $0.50 |
| 52 Week High | $6.43 | $1.15 |
Technical Indicators
Market Signals| Indicator | POM | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 52.54 | 45.77 |
| Support Level | $0.28 | $0.69 |
| Resistance Level | $0.43 | $0.75 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 68.97 | 20.23 |
Price Performance
Historical ComparisonAbout POM POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.